Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 05 Feb 2025 for Spero Therapeutics, Inc.. Read the official filing
Filing timeline
BuySaleSath Shukla
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Sath Shukla: trading record in brief
Sath Shukla (finance chief) discloses dealings in Spero Therapeutics, Inc. to SEC (Form 4). We count 10 filings; the first trade dates from 26 August 2021 and the latest from 3 February 2025.
No open-market purchase appears, only 4 sales worth €29k. Other entries cover 6 share grants.
Most recently, on 5 February 2025, the filings show a share grant in Spero Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sath Shukla
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
751,407 shares0Common StockSEC:0000950170-25-014850:0
2,757 shares@ US$1.3511.5% of flowCommon StockSEC:0000950170-24-101993:0
14,800 shares@ US$1.3262.5% of flowCommon StockSEC:0000950170-24-092170:0
679,501 shares0Common StockSEC:0000950170-24-011487:0
1,854 shares@ US$1.267.4% of flowCommon StockSEC:0000950170-23-045441:0
266,000 shares0Common StockSEC:0000950170-23-037973:0
265,957 shares0Common StockSEC:0000899243-23-003945:0
6,017 shares@ US$0.893818.5% of flowCommon StockSEC:0000899243-22-030087:0
38,014 shares0Common StockSEC:0000899243-22-004593:0
24,067 shares0Common StockSEC:0000899243-21-034498:0
10 of 10 declarations
